# Palliare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/palliare

- Industry: Medical Devices & Equipment
- Headquarters: Galway, Ireland
- Website: www.palliare.com
- Total disclosed funding: $8M
- Latest round: Series A (Jun 28, 2021)
- Investors on record: 3

## About

Founded in 2018 and based in Galway, Ireland, Palliare operates as a developer of smoke evacuation and insufflation technologies for various surgical procedures. The company was a spin-out from Crospon, a gastro-diagnostic company that was acquired by Medtronic in 2017. Mr. Scott Flora serves as the CEO of Palliare. In June 2021, it received its latest series A funding from a group of investors that includes Seroba Life Sciences, SCM AD Venture, and Western Development Commission.

The company's product is called EVA15, a smoke and insufflation system that helps in meeting the standard demands to create a safer operating room environment. It maintains continuous 7-15mmHg pressure and automatically compensates for leaks and suctioning during tool/camera removal and smoke evacuation. The company also offers EndoTrapTM, a tool that helps in reducing the exposure of endoscopists and nurses to airborne particles during endoscopic procedures.

The company's revenue is generated by the sales of its product to medical institutions that perform laparoscopic, endoluminal, endoscopic, and robotic surgery.

The company plans to support US commercial launch activities related to its EVA15 insufflator & smoke evacuation system and new research & development activities.

## Funding rounds

- Series A, Jun 28, 2021, $8M — Seroba, Western Development Commission, SCM AD-Ventures SA

## Investors

- Seroba (https://capitalatlas.ai/funds/seroba) — Series A
- Western Development Commission (https://capitalatlas.ai/funds/western-development-commission) — Series A
- SCM AD-Ventures SA — Series A